MODIFICATION OF THE RADIATION RESPONSE OF PATIENTS WITH
CARCINOMA OF THE UTERINE CERVIX Results of recent NCI trials show a survival
advantage for patients with carcinoma of the uterine cervix treated
with cisplatin-based therapy concurrently with irradiation. Cancer
Control; JMCC 6(4):343-351, 1999 http://oncology.medscape.com/11339.rhtml
<a